Facebook Linkedin RSS Twitter Youtube
Home 2020

Illumina Ventures

Illumina to Acquire Cancer Blood Test Developer GRAIL for $8B
Cancer

Illumina to Acquire Cancer Blood Test Developer GRAIL for $8B

Illumina Bolsters Its Cloud Portfolio with BlueBee Acquisition
News

Illumina Bolsters Its Cloud Portfolio with BlueBee Acquisition

Thermo Fisher to Expand Coronavirus, Infectious Disease Dx with Planned $11.5B QIAGEN Acquisition
Coronavirus

Thermo Fisher to Expand Coronavirus, Infectious Disease Dx with Planned $11.5B QIAGEN Acquisition

Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
Cancer

Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership

Illumina, PacBio Scrap $1.2B Merger, Citing “Continued Uncertainty”
Industry News

Illumina, PacBio Scrap $1.2B Merger, Citing “Continued Uncertainty”

Illumina, Lundbeck Foundation GeoGenetics Centre to Study Microbes’ Role in Neuropsychiatric Disorders
Drug Discovery

Illumina, Lundbeck Foundation GeoGenetics Centre to Study Microbes’ Role in Neuropsychiatric Disorders

Illumina CEO Talks $100 Genome, Tariffs, and NovaSeq at J.P. Morgan
Featured

Illumina CEO Talks $100 Genome, Tariffs, and NovaSeq at J.P. Morgan

Illumina Adds Long-Read Capabilities with $1.2B PacBio Acquisition
Industry News

Illumina Adds Long-Read Capabilities with $1.2B PacBio Acquisition

Genomics Gets Personal
Insights

Genomics Gets Personal

PacBio Sells Sequel System Sequencers to Annoroad
Industry News

PacBio Sells Sequel System Sequencers to Annoroad

1234...15Page 3 of 15
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.